Login     Register  
    Home  |   Your Profile  |   Search  |   About Us  |   Contact Us  |   Disclaimer
BioOntario - Ag Biotech,  Biotechnology and Pharmaceutical Portal for Ontario Canada Blank
Site Search:
    Home Innovation Community Engaged Thinking News Directory Events
 Patient Engagement   Show all: Patient Engagement

WEBINAR: How Pfizer Built a Global Innovator Network
Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions” over scarcely more than two years.
Read More...

Using the Internet to Raise Disease Awareness
The continued rise of social media and the various fundraiser pages can be great for any disease awareness campaign. Patients who have the diseases that are being campaigned for are more likely to engage via social media than the other campaign methods.
Read More...

Strategies for Patient Engagement
Positive and credible engagement of patients is critical for completion of clinical trials and to achieve business results. The CLEAR method leverages: credibility, literacy, expectation management, accessibility and that relates to patients.
Read More...
 
Precision Medicine Intiative
Precision Medicine is an innovative approach that takes into account individual differences in people’s genes, environments, and lifestyles.
Read More...

Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey
This study aims to gain a better understanding of attitudes and practices for engaging patient groups.
 
Partnership between Pharma and Patients
Jane Griffiths, Company Group Chairman, Janssen EMEA discusses the relationship between industry and patients.
Read More...
 
Learning more from Patients Regarding Engagement
What can learn pharma from patients regarding engagement expectations including data collection, communication and the usage of technology.
Read More...

A Focus on People, Ideas and Culture: Bayers Model of Innovation
Bayer's model of innovation is a holistic model for people and their ideas. The model assists with the creation, nurturing, and enhancing of people and ideas.

Engaging patients for drug repurposing: Mapping the patient engagement continuum
November 2015

The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing.
 
Patient Research Priorities
October 2015
Is there a disparity between what patients think are research priorities and the focus of academic/industry studies? Patients become experts in regard to disease and health management; their research priorities can often differ from those of academic/industry based researchers. 
Read More...

P
atient Engagment/Engaged Thinking Social Community Launched
September 18 2015
Visit CanBiotech's new patient engagement and engaged thinking community. Participate in the development of the concept of engaged thinking in health innovation and the identification of "lead patients".
Read More...

 
Listening to Patients
September 2015

In its own move to patient centricity, Sanofi seeks to use practical cases internally to illustrate to staff how things can change toward patient centricity.
Read More...

Fostering Behavior Change for Better Health

Using design thinking, researchers developed five distinct patient segments and created journey maps to chart the experiences of patients from each of these segments from diagnosis to long-term treatment adherence in the context of HIV management.
Read More...

Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes
September 2015

The collaboration will pair Sanofi’s leadership in diabetes treatments and devices with Google’s expertise in analytics, miniaturized electronics and low power chip design. The companies will explore how to improve diabetes care by developing new tools that bring together many of the previously siloed pieces of diabetes management and enable new kinds of interventions. This includes health indicators such as blood glucose and hemoglobin A1c levels, patient-reported information, medication regimens and sensor devices.

Read More...

The Lilly COI API and TrialReach: A Story of Innovation
August 2015

A vision for inclusive and participatory clinical knowledge generation, with particpation by all including patients in the clinical research ecosystem. Participatory is at the core of open innovation at Lilly.
Read More...

Patient Engagement and Cultural Competence
July 2015

Should the pharmaceutical industry consider cultural competence a driver for more holistic patient engagement? Care providers and health care organizations are seeking to align patient engagement and cultural competency to better understand disease management and compliance issues.
Read More...

Pfizer's Global Innovation Network
June 2015

In this webinar, Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions”.
Read More...

An Interview with Novartis
June 2015

In this interview, the CEO of Swiss pharmaceutical company Novartis, Joseph Jimenez, discusseshow digitization is driving innovation, and why Novartis is shifting to an outcomes-based approach for patient treatments.
Read More...


Pharma Behind Other Industries in Customer Engagement

Expanded Patient Role
June 2015

Patient engagement can be traced across the drug-development pipeline including the impact of recent policy initiatives, and prospects moving forward.
Read More...

Exploring open innovation with a patient focus in drug discovery: an evolving paradigm of patient engagement
It is suggested in this article that patient engagement should occur further upstream during the drug discovery stage. ‘Lead patients’, namely those patients who are proactive with respect to their health, possess knowledge of their disease and resulting symptoms. They are also well informed about the conventional as well as non-conventional treatments for disease management; and so can provide a nuanced perspective to drug design.
Read More:
http://informahealthcare.com/doi/abs/10.1517/17460441.2015.1037271


Using the Site Privacy & Security Statement Advertise with us Directory Guide & Access Policy Event Postings CanBiotech Newsletters

© 2000-2017 CanBiotech™ Inc.